Terry-Ann Burrell
2021
In 2021, Terry-Ann Burrell earned a total compensation of $3.9M as CFO at Beam Therapeutics, a 476% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $229,320 |
|---|---|
| Option Awards | $1,850,681 |
| Salary | $441,000 |
| Stock Awards | $1,400,700 |
| Other | $17,203 |
| Total | $3,938,904 |
Burrell received $1.9M in option awards, accounting for 47% of the total pay in 2021.
Burrell also received $229.3K in non-equity incentive plan, $441K in salary, $1.4M in stock awards and $17.2K in other compensation.
Rankings
In 2021, Terry-Ann Burrell's compensation ranked 3,400th out of 12,415 executives tracked by ExecPay. In other words, Burrell earned more than 72.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,400 out of 12,415 | 73rd |
Division Manufacturing | 1,379 out of 5,508 | 75th |
Major group Chemicals And Allied Products | 559 out of 2,378 | 77th |
Industry group Drugs | 498 out of 2,099 | 76th |
Industry Biological Products, Except Diagnostic Substances | 133 out of 449 | 70th |
Source: SEC filing on April 22, 2022.
Burrell's colleagues
We found two more compensation records of executives who worked with Terry-Ann Burrell at Beam Therapeutics in 2021.